...
首页> 外文期刊>Pharmacology: International Journal of Experimental and Clinical Pharmacology >Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase.
【24h】

Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase.

机译:白三烯对关节炎大鼠离体心脏的冠状动脉血管收缩的作用:用环氧化酶和脂氧化酶的双重抑制剂CI-986进行体内治疗的效果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, coronary perfusion pressure and force of contraction were investigated in isolated hearts removed from arthritic rats by using the Langendorff method. A strong coronary vasoconstriction was determined in arthritic hearts which was associated with elevated levels of arachidonate 5-lipoxygenase (5-LOX) products, leukotriene B(4) (LTB(4)) and LTC(4) in coronary effluents. In vivo treatment with the dual inhibitor of cyclooxygenase (COX) and LOX, CI-986 (2 and 10 mg/kg/day) on days 14- 26 following adjuvant injection, prevented the coronary vasoconstriction and the increased production of LTB(4) and LTC(4). These results suggest that the coronary vasoconstriction in the isolated arthritic hearts is associated with an increased activity of the LOX system and CI-986 could have a preventive effect on constriction of coronary arteries. Copyright 2000 S. Karger AG, Basel
机译:在这项研究中,使用Langendorff方法研究了从关节炎大鼠中分离出的离体心脏中的冠状动脉灌注压力和收缩力。在关节炎的心脏中确定了强烈的冠状动脉血管收缩,这与冠状流出物中花生四烯酸5-脂氧合酶(5-LOX)产品,白三烯B(4)(LTB(4))和LTC(4)的水平升高有关。佐剂注射后第14-26天用环氧合酶(COX)和LOX的双重抑制剂CI-986(2和10 mg / kg /天)进行体内治疗可防止冠状动脉血管收缩和LTB产生增加(4)和LTC(4)。这些结果表明,离体的关节炎心脏中的冠状动脉血管收缩与LOX系统活性增加有关,CI-986可能对冠状动脉的收缩具有预防作用。版权所有2000 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号